Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical does not pass the values gate
Price17.72 USD
Fair value13.66
Ethical score70.0/100
Our investment reviews on this name
2026-09-17Read Markdown17.54+1.0% to today
2026-07-02Read Markup19.45-8.9% to today
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Xenia Hotels & Resorts, Inc. holds its Markdown at $17.72. The statistical read favours the sellers, held for 262 days.
As held on the ledger · 2026-09-18
Phase
Markdown · caution
Quantitative state
The statistical read favours the sellers, held for 262 days
Price at the screen
$17.72
Valuation
N/A trailing · 27.91 forward price to earnings
Values screen
FAIL· score 70.0
Beta
1.16
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
50.93%
Below 33%
Interest-bearing debt is 50.9% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
5.96%
Below 49%
Money owed to the company is 6.0% of assets, under the 49% limit.
Pass
Revenue purity
0.00%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
Fair value range in USD, drawn from the 2026-09-18 screen. The gold marker is the market price at the same screen. The price runs 22.9% above the base estimate.
Third-party analyst targets: 5 covering, consensus Buy. The average target sits +19% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-18 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Hotel REIT priced well above its real worth
Picture a string of upscale resorts humming with guests yet delivering only 2% revenue growth and a 6% profit margin. Xenia owns thirty such properties in prime US markets, but at a $21 share price against our $12.55 fair value it offers no margin of safety and a 39.3 times forward earnings multiple that assumes far more than the 6% return on equity it actually produces.
We therefore pass. The business clears our ethical screen, yet the combination of negligible growth, thin returns and a valuation that sits well above both our assessment and the $20 analyst median target leaves nothing compelling on the table.
Cyclical hotel demand can swing sharply with travel trends and the economy, so the current multiple risks turning into a trap if earnings disappoint. Analysis, not advice.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
XHR trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-09-17Markdown · changed$17.54-6.7%Entry 5
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 6.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 21% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 53%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (5 analysts) rates it buy, with a mean price target of $17.
2026-08-18Markup$18.80-3.3%Entry 4
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 3.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 21% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 53%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (5 analysts) rates it buy, with a mean price target of $17.
2026-07-18Markup$19.45+0.0%Entry 3
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 21% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 53%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (5 analysts) rates it buy, with a mean price target of $17.
2026-07-03Markup$19.45+0.0%Entry 2
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
2026-07-02Markup$19.45Entry 1
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
